Illuminant’s team recently traveled to New York City to showcase its platform to top neurosurgeons at Mount Sinai, including Chairman Dr. Joshua Bederson and Vice-Chair Dr. J Mocco. The demonstration highlighted Illuminant’s ability to simplify surgical workflows while maintaining precision. Engagement with leading institutions like Mount Sinai reinforces Illuminant’s commitment to real-world clinical adoption.

By presenting directly to key decision-makers in neurosurgery, Illuminant is actively shaping the future of surgical navigation adoption. The enthusiasm from top surgeons not only validates the company’s technology but also strengthens its network of clinical advocates, a critical factor in widespread market penetration.